期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
immunomodulatory effects of dexmedetomidine: from bench to clinic 被引量:3
1
作者 Carlos Rodrigo Camara-Lemarroy Erick Joel Rendon-Ramirez beatriz elena ibarra-yruegas 《World Journal of Anesthesiology》 2014年第2期137-145,共9页
Dexmedetomidine is a central alpha2-adrenergic receptor agonist with sedative and analgesic properties that has a proven safety profile. It has several beneficial effects such as decreasing sympathetic tone, leading t... Dexmedetomidine is a central alpha2-adrenergic receptor agonist with sedative and analgesic properties that has a proven safety profile. It has several beneficial effects such as decreasing sympathetic tone, leading to reduced opiate use and anxiolysis, making it an attractive option for sedation in the perioperative and intensive care unit setting. These effects also modify favorably the time spent on a ventilator, intensive care unit length of stay and development of delirium. Recent studies also suggest that dexmedetomidine possesses wide-ranging immunomodulating properties. It has been associated with reduced inflammatory cytokine release, modulation of inflammatory transcription factors, oxidative stress and inflammatory cells. These properties could be beneficial in the context of inflammatory conditions that require sedation, such as sepsis, ischemia-reperfusion injury and ventilator-associated lung injury, among many others. In this review, we propose specific clinical scenarios where these properties could turn out to be clinically relevant. 展开更多
关键词 DEXMEDETOMIDINE IMMUNOMODULATION Inflammation SEPSIS ANESTHESIA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部